Entry |
|
Name |
3,4-Dihydroxy-L-phenylalanine;
L-Dopa;
3-Hydroxy-L-tyrosine;
L-beta-(3,4-Dihydroxyphenyl)alanine;
Levodopa;
Dihydroxy-L-phenylalanine
|
Formula |
C9H11NO4
|
Exact mass |
197.0688
|
Mol weight |
197.19
|
Structure |

|
Remark |
|
Reaction |
|
Pathway |
map00950 | Isoquinoline alkaloid biosynthesis |
map01060 | Biosynthesis of plant secondary metabolites |
map01063 | Biosynthesis of alkaloids derived from shikimate pathway |
map01110 | Biosynthesis of secondary metabolites |
|
Module |
M00042 | Catecholamine biosynthesis, tyrosine => dopamine => noradrenaline => adrenaline |
M00961 | Betacyanin biosynthesis, L-tyrosine => amaranthin |
|
Network |
|
Enzyme |
|
Brite |
Compounds with biological roles [BR:br08001]
Peptides
Amino acids
Other amino acids
C00355 3,4-Dihydroxy-L-phenylalanine
Hormones and transmitters
Neurotransmitters
Amino acids
C00355 Dopa
Prodrugs [br08324.html]
C00355
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N04 ANTI-PARKINSON DRUGS
N04B DOPAMINERGIC AGENTS
N04BA Dopa and dopa derivatives
N04BA01 Levodopa
D00059 Levodopa (JP18/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Antiparkinson Agents
Dopamine Precursors and/or L-Amino Acid Decarboxylase Inhibitors
Levodopa
D00059 Levodopa (JP18/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
116 Antiparkinsonian agents
1164 Levodopas
D00059 Levodopa (JP18/USP/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01472 Dopamine agonist
D00059 Levodopa
DG01967 Antiparkinson agent
D00059 Levodopa
Drug classes [BR:br08332]
Neuropsychiatric agent
DG01967 Antiparkinson agent
D00059 Levodopa
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Dopamine
DRD
D00059 Levodopa (JP18/USP/INN) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00059 Levodopa
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D00059
Prodrugs [br08324.html]
D00059
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 14
1 C8y C 22.9600 -19.2500
2 C8y C 22.9600 -20.6500
3 C8x C 24.1500 -18.5500
4 O1a O 21.7000 -18.5500
5 C8x C 24.1500 -21.3500
6 O1a O 21.7000 -21.3500
7 C8y C 25.3400 -19.2500
8 C8x C 25.3400 -20.6500
9 C1b C 26.6000 -18.6200
10 C1c C 27.7900 -19.2500
11 C6a C 28.9800 -18.6200
12 N1a N 27.7900 -20.6500
13 O6a O 30.2400 -19.2500
14 O6a O 28.9800 -17.2200
BOND 14
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 2
5 2 6 1
6 3 7 1
7 5 8 1
8 7 9 1
9 9 10 1
10 10 11 1
11 10 12 1 #Up
12 11 13 1
13 11 14 2
14 7 8 2
|